PF Absorbance (490 nm) ± SEM % viability Fold change, with respect to Control TG TG-F Control 0.945 ± 0.11 100.00       TG24 0.769 ± 0.08 81.33 (-) 1.23     TG24F 0.882 ± 0.27 93.29   (+) 1.15   TG24MF 0.891 ± 0.20 94.31   (+) 1.16 (+) 1.01 TG48 0.722 ± 0.18 76.42 (-) 1.31     TG48F 0.892 ± 0.05 94.36   (+) 1.23   TG48MF 0.793 ± 0.21 83.85   (+) 1.10 (-) 1.13 TG72 0.577 ± 0.09 61.06 (-) 1.64     TG72F 0.804 ± 0.02 85.08   (+) 1.39   TG72MF 0.921 ± 0.24 97.50   (+) 1.60 (+) 1.15 TG96 0.554 ± 0.17 58.66 (-) 1.70     TG96F 0.785 ± 0.17 83.11   (+) 1.42   TG96MF 0.750 ± 0.24 79.33   (+) 1.35 (-) 1.05 (#: p<0.05 versus Control; *: p<0.05 versus TG; *: p<0.05 versus TG-F)

Table 9: Fold changes in viability of cells in peritoneal fluid, assayed by MTS reagent, at 492 nm. With fisetin, there is a 1.15 fold increase after 24 h, a 1.23 fold increase after 48 h, a 1.39 fold increase after 72 h and a 1.42 fold increase after 96 h, in the cell viability. With MCN+fisetin, cell viability increased 1.16 fold after 24 h, 1.10 fold after 48 h, 1.60 fold after 72 h and 1.35 fold after 96 h.